Prostatic adenocarcinoma. Considerations in management

D. A. Pistenma, M. A. Bagshaw

Research output: Contribution to journalArticle

Abstract

Management of prostatic adenocarcinoma depends on the extent of disease as determined by staging procedures: digital rectal examination, histologic grading of the tissue specimen, and evaluation for dissemination of disease to bone and other distant sites. At this time there is no curative treatment for patients with widespread bone or visceral metastases. When the cancer is histologically confined to the gland and there are no lymph node or other metastases, total prostatectomy should be curative. Other therapeutic options with comparable success are external beam radiation and interstitial implantation of iodine 125 radioactive seeds. Pelvic lympho node dissection is appropriately used to assess the status of nodes prior to prostatectomy or implantation of radioactive seeds. Its therapeutic effectiveness has not yet been proved.

Original languageEnglish (US)
Pages (from-to)135-145
Number of pages11
JournalPostgraduate Medicine
Volume67
Issue number4
StatePublished - 1980

Fingerprint

Adenocarcinoma
Prostatectomy
Seeds
Neoplasm Metastasis
Digital Rectal Examination
Bone Diseases
Iodine
Dissection
Therapeutics
Lymph Nodes
Radiation
Bone and Bones
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pistenma, D. A., & Bagshaw, M. A. (1980). Prostatic adenocarcinoma. Considerations in management. Postgraduate Medicine, 67(4), 135-145.

Prostatic adenocarcinoma. Considerations in management. / Pistenma, D. A.; Bagshaw, M. A.

In: Postgraduate Medicine, Vol. 67, No. 4, 1980, p. 135-145.

Research output: Contribution to journalArticle

Pistenma, DA & Bagshaw, MA 1980, 'Prostatic adenocarcinoma. Considerations in management', Postgraduate Medicine, vol. 67, no. 4, pp. 135-145.
Pistenma, D. A. ; Bagshaw, M. A. / Prostatic adenocarcinoma. Considerations in management. In: Postgraduate Medicine. 1980 ; Vol. 67, No. 4. pp. 135-145.
@article{d4667a1414e548e5a06bd368213344b4,
title = "Prostatic adenocarcinoma. Considerations in management",
abstract = "Management of prostatic adenocarcinoma depends on the extent of disease as determined by staging procedures: digital rectal examination, histologic grading of the tissue specimen, and evaluation for dissemination of disease to bone and other distant sites. At this time there is no curative treatment for patients with widespread bone or visceral metastases. When the cancer is histologically confined to the gland and there are no lymph node or other metastases, total prostatectomy should be curative. Other therapeutic options with comparable success are external beam radiation and interstitial implantation of iodine 125 radioactive seeds. Pelvic lympho node dissection is appropriately used to assess the status of nodes prior to prostatectomy or implantation of radioactive seeds. Its therapeutic effectiveness has not yet been proved.",
author = "Pistenma, {D. A.} and Bagshaw, {M. A.}",
year = "1980",
language = "English (US)",
volume = "67",
pages = "135--145",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "4",

}

TY - JOUR

T1 - Prostatic adenocarcinoma. Considerations in management

AU - Pistenma, D. A.

AU - Bagshaw, M. A.

PY - 1980

Y1 - 1980

N2 - Management of prostatic adenocarcinoma depends on the extent of disease as determined by staging procedures: digital rectal examination, histologic grading of the tissue specimen, and evaluation for dissemination of disease to bone and other distant sites. At this time there is no curative treatment for patients with widespread bone or visceral metastases. When the cancer is histologically confined to the gland and there are no lymph node or other metastases, total prostatectomy should be curative. Other therapeutic options with comparable success are external beam radiation and interstitial implantation of iodine 125 radioactive seeds. Pelvic lympho node dissection is appropriately used to assess the status of nodes prior to prostatectomy or implantation of radioactive seeds. Its therapeutic effectiveness has not yet been proved.

AB - Management of prostatic adenocarcinoma depends on the extent of disease as determined by staging procedures: digital rectal examination, histologic grading of the tissue specimen, and evaluation for dissemination of disease to bone and other distant sites. At this time there is no curative treatment for patients with widespread bone or visceral metastases. When the cancer is histologically confined to the gland and there are no lymph node or other metastases, total prostatectomy should be curative. Other therapeutic options with comparable success are external beam radiation and interstitial implantation of iodine 125 radioactive seeds. Pelvic lympho node dissection is appropriately used to assess the status of nodes prior to prostatectomy or implantation of radioactive seeds. Its therapeutic effectiveness has not yet been proved.

UR - http://www.scopus.com/inward/record.url?scp=0018829783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018829783&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 135

EP - 145

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 4

ER -